Archive for November 17th, 2008

Pharma Marketletter - Merck & Co’s Cozaar gets US approval for stroke prevention.

Monday, November 17th, 2008

Merck & Co’s angiotensin II receptor antagonist Cozaar (losartan) has become the first and only antihypertensive to be approved in the USA for reducing the risk of stroke in patients with high blood pressure and left ventricular hypertrophy, which can be a precursor to heart failure. However, new labeling for the product indicates that this …

Related Results